References
- BARTELS, M. J., HANSEN, S. C., THORNTON, C. M., BRZAK, K. A. and MENDRALA, A. L., 2003, Metabolism of 14C-labeled 1,3-dichloropropene in F344 rats and B6C3F1 mice. Paper presented at the 51st American Society for Mass Spectrometry Annual Meeting, 8–12 June, Montreal, Canada.
- BOATMAN, R. J., 2001, Glycol ethers: ethers of propylene, butylene glycols, and other glycol derivatives. In E. Binghan, B. Cohrssen and C. H. Powell (eds), Patty's Toxicology, vol. 7, 5th edn (New York: Wiley), pp. 271–395.
- BRESLIN, W. J., PHILLIPS, J. E., LOMAX, L. G., BARTELS, M. J., DITTENBER, D. A., CALHOUN, L. L. and MILLER, R. R., 1991, Hemolytic activity of ethylene glycol phenyl ether (EGPE) in rabbits. Fundamentals in Applied Toxicology, 17, 466–481.
- CAPEL, I. D., FRENCH, M., MILLBURN, P., SMITH, R. L. and WILLIAMS, R. T., 1972, The fate of [14q-phenol in various species. Xenobiotica, 2, 25–34.
- DOMORADZKI, J. Y., STEWART, H. S., MENDRALA, A. L., GILBERT, J. R. and MARKHAM, D. A., 1996, Comparison of the metabolism and tissue distribution of 14C-labeled spinosyn A and 14C-labeled spinosyn D in Fischer 344 rats. Toxicologist, 30, 35.
- EDWARDS, V. T., JONES, B. C. and HUTSON, D. H., 1986, A comparison of the metabolic fate of phenol, phenyl glucoside and phey1-6-0-malonyl-glucoside in the rat. Xenobiotica, 16, 801-807. HUGHES, M. F. and HALL, L. L., 1995, Disposition of phenol in rat after oral, dermal, intravenous, and intratracheal administration. Xenobiotica, 25, 873–883.
- KAO, J., BRIDGES, J. W. and FAULKNER, J. K., 1979, Metabolism of [14C]phenol by sheep, pig and rat. Xenobiotica, 9, 141–147.
- MILLER, R. R., HERMANN, E. A., LANGVARDT, P. W., MCKENNA, M. J. and SCHWETZ, B. A., 1983, Comparative metabolism and disposition of ethylene glycol monomethyl ether and propylene glycol monomethyl ether in male rats. Toxicology and Applied Pharmacology, 67, 229–237.
- MUTLIB, A. E., CHEN, H., NEMETH, G., GAN, L. S. and CHRIST, D. D., 1999, Liquid chromatography/ Mass spectrometry and high-field nuclear magnetic resonance characterization of novel mixed diconjugates of the non-nucleoside human immunodeficiency virus-1 reverse transcriptase inhibitor, efavirenz. Drug Metabolism and Disposition, 27, 1045–1056.